Tradestie Institutional Equity Comparison Engine
PACS vs DVA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DVA Overall Edge
DVA Captures Institutional Edge (2โ2 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DaVita Inc. (DVA) driven by superior Valuation, Growth & Margin while PACS counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PACS trades at 15.3x Forward P/E with 7.4% operating margin (+11.5% YoY revenue) versus DVA at 9.5x Forward P/E and 15.2% operating margin (+4.6% YoY). In options structure, PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against DVA sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DVA
PACS 15.3x vs DVA 9.5x Fwd P/E
Growth & Margin Winner
DVA
Op Margin 7.4% vs 15.2% ยท YoY +11.5% vs +4.6%
Momentum & Technical Winner
PACS
1Y +159.5% vs +39.8% ยท 52W Pos 79% vs 41%
Options & Structure Winner
PACS
CONSOLIDATION (11th %ile IV) vs BREAKDOWN (7th %ile IV)
PACS
NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap
$6.8B
1M Return
-8.06%
1Y Return
+159.48%
Forward P/E
15.3x
Unified AI Score
46.8 / 100
HOLD
Tech 35.0
Fund 48.0
Flow 62.0
Mom 50.0
DVA
NYSE
DaVita Inc.
Services-Misc Health & Allied Services, Nec
$161.03
+3.0% 1D
Market Cap
$9.8B
1M Return
-13.47%
1Y Return
+39.78%
Forward P/E
9.5x
Unified AI Score
48.8 / 100
HOLD
Tech 54.0
Fund 58.0
Flow 58.0
Mom 66.4
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PACS +159.48%
DVA +39.78%
Spread: +119.7 pp (PACS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PACS Revenue | DVA Revenue | PACS Op. Margin | DVA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $11.4B | N/A | 13.4% | DVA |
| FY2019 | N/A | $11.4B | N/A | 14.4% | DVA |
| FY2020 | N/A | $11.6B | N/A | 14.7% | DVA |
| FY2021 | N/A | $11.6B | N/A | 15.5% | DVA |
| FY2022 | $2.40B | $11.6B | 9.6% | 11.5% | DVA |
| FY2023 | $3.11B | $12.1B | 6.7% | 13.2% | DVA |
| FY2024 | $4.09B | $12.8B | 3.0% | 16.3% | DVA |
| FY2025 | $5.29B | $13.6B | 5.9% | 15.0% | DVA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PACS | DVA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.8B | $9.8B | Larger Scale | DVA |
| Trailing P/E Ratio Valuation | 26.2x | 11.8x | Lower Multiple | DVA |
| Forward P/E Ratio Valuation | 15.3x | 9.5x | Lower Multiple | DVA |
| Revenue Growth (YoY) Growth | +11.5% | +4.6% | Higher Growth | PACS |
| Operating Margin (TTM) Profitability | 7.4% | 15.2% | Higher Margin | DVA |
| Net Profit Margin Profitability | 4.9% | 6.5% | Higher Margin | DVA |
| Return on Equity (ROE) Capital Efficiency | 26.5% | 96.8% | Higher ROE | DVA |
| 52-Week Range Position Momentum | 79% ($14โ$52) | 41% ($101โ$247) | Stronger Trend | PACS |
| Beta / 30D Volatility Risk Regime | 0.78ฮฒ ยท 51% Vol | 0.15ฮฒ ยท 48% Vol | Lower Realized Risk | DVA |
| Unified Institutional Score Composite Signal | 46.8 / 100 (HOLD) | 48.8 / 100 (HOLD) | Higher Composite | DVA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PACS vs DVA Buy Guide
PACS
CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
DVA
BREAKDOWN
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PACS nor DVA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.